Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Emmanuelle Pourcher »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Emmanuelle Leray < Emmanuelle Pourcher < Emmanuelle Uro-Coste  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000098 (2012) Bruno Dubois [France] ; Eduardo Tolosa ; Regina Katzenschlager ; Murat Emre ; Andrew J. Lees ; Günther Schumann ; Emmanuelle Pourcher ; Julian Gray ; Gail Thomas ; Jina Swartz ; Timothy Hsu ; Margaret L. MolineDonepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.
000126 (2012) Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Gunther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis]Donepezil in Parkinson's Disease Dementia: A Randomized, Double-Blind Efficacy and Safety Study
000670 (1989) Emmanuelle Pourcher [France] ; Anne-Marie Bonnet [France] ; John Kefalos [France] ; Bruno Dubois [France] ; Agid [France]Effects of etybenzatropine and diazepam on levodopa‐induced diphasic dyskinesias in Parkinson's disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Humans
2Middle Aged
2Nervous system diseases
2Parkinson Disease (drug therapy)
2Parkinson disease
1Adult
1Aged
1Aged, 80 and over
1Analysis of Variance
1Antagonist
1Anticonvulsant
1Benzodiazepine derivatives
1Chemotherapy
1Cholinergic receptor
1Cholinesterase
1Cholinesterase Inhibitors (therapeutic use)
1Cognition
1Dementia
1Dementia (complications)
1Dementia (drug therapy)
1Diazepam
1Diazepam (therapeutic use)
1Donepezil
1Dopa
1Dose-Response Relationship, Drug
1Double blind study
1Double-Blind Method
1Drug interaction
1Dyskinesia
1Dyskinesias
1Etybenzatropine
1Europe
1Executive function
1Female
1Human
1Indans (therapeutic use)
1Intramuscular administration
1Intravenous administration
1Levodopa
1Levodopa (adverse effects)
1Levodopa (therapeutic use)
1Male
1Movement Disorders (chemically induced)
1Movement Disorders (drug therapy)
1Parkinson Disease (complications)
1Parkinson's Disease
1Pilot Projects
1Piperidines (therapeutic use)
1Prevention
1Psychiatric Status Rating Scales
1Psychotropic
1Safety
1Toxicity
1Treatment
1Tropanes (therapeutic use)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Emmanuelle Pourcher" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Emmanuelle Pourcher" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Emmanuelle Pourcher
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024